Randomized Trial in Unfit, Elderly Chronic Lymphocytic Leukemia (CLL) Patients with Comorbidities of Dose-Reduced Oral Fludarabine and Cyclophosphamide Plus Obinutuzumab (FC+G) Versus Chlorambucil Plus Obinutuzumab (Cbl+G) As Front-Line Therapy

Stephen P. Mulligan, Jane Freeman, Xavier C. Badoux, Richard Eek, Gavin Cull, Naomi Mackinlay, Nicholas Murphy, Duncan Carradice, Ann Solterbeck, Oliver G. Best,, Constantine Tam, Bryone Kuss

Research output: Contribution to journal › Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'Randomized Trial in Unfit, Elderly Chronic Lymphocytic Leukemia (CLL) Patients with Comorbidities of Dose-Reduced Oral Fludarabine and Cyclophosphamide Plus Obinutuzumab (FC+G) Versus Chlorambucil Plus Obinutuzumab (Cbl+G) As Front-Line Therapy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science